Sign in

CIK 0001620463

  • Non-accelerated filer
  • Smaller reporting company

LeonaBio, Inc.

Sign in to watch
Ticker
LONA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
453368487
Phone
+1 425-620-8501
Business address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
Former names
Athira Pharma, Inc., M3 Biotechnology, Inc.
  1. 4/A Open-market sale GENERAL COUNSEL sold 2,412 shares at $2.91 ($7,019)
  2. 4/A Open-market sale CFO AND CHIEF BUSINESS OFFICER sold 1,208 shares at $2.91 ($3,515)
  3. 4/A Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,412 shares at $2.91 ($7,019)
  4. 4 Grant or award Chief Medical Officer acquired 10,000 shares (grant or award)
  5. 4 Open-market sale Gengos Andrew sold 1,208 shares at $2.91 ($3,515)
  6. 4 Open-market sale Chief Executive Officer sold 4,820 shares at $2.91 ($14,026)
  7. 4 Open-market sale General Counsel sold 2,412 shares at $2.91 ($7,019)
  8. 4 Open-market sale Chief Scientific Officer sold 2,412 shares at $2.91 ($7,019)
  9. 4 Open-market sale Chief Operating Officer sold 2,412 shares at $2.91 ($7,019)
  10. 4 Open-market buy Director bought 605,686 shares at an average $2.42 ($1,462,895)
  11. 4 Open-market buy Gengos Andrew bought 15,000 shares at an average $3.43 ($51,445)
  12. 4 Open-market buy Gengos Andrew bought 65,012 shares at an average $2.95 ($191,572)
  13. 4 Grant or award Chief Medical Officer acquired 7,764 shares (grant or award)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 11 · 211 filings